Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
16-18 March, 2026
Food Ingredients Chin... Food Ingredients China
Not Confirmed
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Not Confirmed
Not Confirmed
17-19 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
16-18 March, 2026
Food Ingredients Chin... Food Ingredients China
Industry Trade Show
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Industry Trade Show
Not Confirmed
17-19 March, 2026
Digital content

07 Oct 2025
// PRESS RELEASE
https://www.merck.com/news/merck-completes-acquisition-of-verona-pharma/

16 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/16/3150586/0/en/Verona-Pharma-to-Present-Additional-Analyses-of-the-Phase-3-ENHANCE-Studies-in-COPD-at-ERS-International-Congress-2025.html

07 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/its-10b-buyout-verona-merck-was-lone-ranger

10 Jul 2025
// PRESS RELEASE
https://www.merck.com/news/merck-to-acquire-verona-pharma-expanding-its-portfolio-to-include-ohtuvayre-ensifentrine-a-first-in-class-copd-maintenance-treatment-for-adults-and-expected-to-drive-growth-into-the-next-dec/

21 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/21/3085542/0/en/Verona-Pharma-Announces-June-2025-Investor-Conference-Participation.html

06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3074811/0/en/Verona-Pharma-to-Present-Seven-Analyses-of-the-Phase-3-ENHANCE-Studies-in-COPD-at-ATS-2025.html
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Dosage Form : SUSPENSION; INHALATION
Proprietary Name : OHTUVAYRE
Dosage Strength : 3MG/2.5ML
Approval Date : 2024-06-26
Application Number : 217389
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : United Kingdom
Dosage Form :
Brand Name : Ohtuvayre
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : United Kingdom

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE